Investment
Features
FeesSafety
Academy
More
Pluang+

Rexford Industrial to report Q3 2026 earnings on October 22 with a conference call on October 23

Company Fundamentals
28 Sep 2026
PRNewsWire
View Source
Neutral
Rexford Industrial to report Q3 2026 earnings on October 22 with a conference call on October 23

Rexford Industrial Realty, a real estate investment trust focused on industrial properties in Southern California, announced it will release its third quarter 2026 financial results after market close on October 22, 2026. A conference call with senior management is scheduled for October 23 to discuss the results. This update is important for investors tracking Rexford's performance in the industrial real estate sector and its impact on shareholder value. The company also provided details for accessing the call and webcast.

Rexford Industrial's upcoming Q3 2026 earnings release and conference call provide context for real estate market watchers. For readers following the US Real Estate sector, here is Pluang's market snapshot as of Sep 29, 2026 03:01 WIB: out of 26 priced stocks, 8 rose and 16 fell. Jones Lang LaSalle Inc (JLL) traded at USD 313.48 with a 1-day change of -2.62%, while AGNC Investment Corp (AGNC) was at USD 9.45 with a -1.77% change and a Pluang order activity of 26% Sell / 74% Buy.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
1 hour ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
1 hour ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
2 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
2 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App